NEW YORK (GenomeWeb News) – Singapore's PathGen Dx will develop a pathogen detection diagnostic kit based on the Affymetrix GeneChip platform, the companies said today.

PathGen Dx, a spinoff from the Genome Institute of Singapore, plans to develop a test called the PathChip that will detect the presence of more than 70,000 viral and bacterial genomes in human samples and identify co-infecting pathogens.

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

The United Nations is to consider a ban on field testing gene drives at a meeting being held next week, Technology Review reports.

The Associated Press reports that gene-edited food may soon be for sale.

The US Department of Health and Human Services is beginning a series of meetings on human fetal tissue research, Stat News reports.

In Cell this week: epigenetic change linked to glioblastomas, rare and low-frequency variants contributing to multiple sclerosis risk, and more.